Diagnosis of Pheochromocytoma
Phase 1
3,000
about 49 years
3–120
1 site in MD
What this study is about
This trial is testing new ways to diagnose, locate, and treat pheochromocytomas. These tumors can be difficult to detect with current methods and release chemicals that cause high blood pressure. Patients may be eligible for it if they have a pheochromocytoma. It involves screening patients with medical tests and imaging scans, including PET scans using radioactive compounds like 18F-FDOPA or 18F-DA. Genetic testing is also performed.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take ([18F]-6F-DA)
- 2.Take ([18F]-DOPA)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
levodopa
Primary: To study specific genotypes, biochemical and imaging phenotypes of patients with various pheochromocytomas and paragangliomas.To stuty potential treatment options for metastatic pheochromocytoma and paraganglioma using cell cultures, cell ...
Endocrinology